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Abstract 
The importance of microenvironment and context in regulation of tissue-specific genes is 
finally well established.  DNA exposure to, or sequestration from, nucleases can be used 
to detect differences in higher order chromatin structure in intact cells without disturbing 
cellular or tissue architecture. To investigate the relationship between chromatin 
organization and tumor phenotype, we utilized an established 3-D assay where normal 
and malignant human breast cells can be easily distinguished by the morphology of the 
structures they make (acinus-like vs tumor-like, respectively). We show that these 
phenotypes can be distinguished also by sensitivity to AluI digestion where the 
malignant cells are resistant to digestion relative to non-malignant cells. Reversion of the 
T4-2 breast cancer cells by either cAMP analogs, or a phospatidylinositol 3-kinase 
(P13K) inhibitor not only reverted the phenotype, but also the chromatin sensitivity to 
AluI. By using different cAMP-analogs, we show that the cAMP-induced phenotypic 
reversion, polarization, and shift in DNA organization act through a cAMP-dependent-
protein-kinase A-coupled signaling pathway. Importantly, inhibitory antibody to 
fibronectin also reverted the malignant phenotype, polarized the acini, and changed 
chromatin sequestration. These experiments show not only that modifying the tumor 
microenvironment can alter the organization of tumor cells but also that architecture of 
the tissues and the global chromatin organization are coupled and yet highly plastic. 
 
Introduction 
We have shown previously that the degree of malignancy, the organization of 
cytoskeleton, and the composition of the extracellular matrix (ECM) influence chromatin 
structure (Maniotis et al., 2005). We found that the DNA of cultured cell lines from 
malignant tumors, transformed fibroblasts harboring 3 oncogenes, and cells collected 
from human tumors were more resistant to nucleases compared to DNA from normal or 
nonmalignant and weakly malignant cells. In addition, cells with the same genotype 
exhibit different degrees of DNA sequestration and exposure when cytoskeletal 
components were selectively disrupted, or when they were cultured on different ECM 
components (Maniotis et al., 2005). 
 
Without viral insertion, additional deletion, or mutation of genes, it is possible to revert 
malignant tumor cells into cells those behave phenotypically normal. On 2-dimensional 
(2-D) surfaces, malignant cells can be induced by addition of cAMP to cease blebbing, 
form an organized cytoskeleton, and develop contact-inhibited monolayers (Krystosek et 
al., 1990; Puck et al., 2002). In a 3-dimensional (3-D) tissue culture system, it is possible 
to induce breast cancer cells to form normal tissue structures resembling breast acini 
(Wang et al., 2002; Weaver et al., 2002; Weaver et al., 1997). In experimental animal 
models, teratocarcinoma cells placed into mammalian embryos (Mintz and Illmensee, 
1975), avian embryos transformed with Rous sarcoma virus (Dolberg and Bissell, 1984), 
and metastatic, aneuploid melanoma cells placed in chick embryos (Kulesa et al., 2006) 
develop into normal structures and tissues, and do not form tumors as they would in the 
adult organisms. These findings demonstrate that the phenotypes of malignant, 
metastatic, or transformed cells are highly plastic and regulated by the environment in 
which they are placed. The mechanisms underlying these phenotypic plasticities are not 
understood. In addition, it is not known if changes in cell phenotype are accompanied by 
epigenetic changes in DNA organization.  
  
Here we have employed a well-characterized, phenotypically breast tumor model system 
in 3-D (Bissell and Labarge, 2005; Petersen et al., 1992; Weaver et al., 1997) to 
determine whether the transition of a tumor cells from disorganized clusters to 
organized, polar acinus-like structures is accompanied by global epigenetic changes in 
chromatin structure that could be quantified using the degree of resistance to DNA-
degrading enzymes.  We show that the organization of DNA in a malignant, mammary 
epithelial cell line follows tissue architecture. Moreover, tissue phenotype, and DNA 
organization are plastic, and reversible. We take advantage of these observations to test 
the following question: Through manipulation of single molecules in the 
microenvironment, is it possible to reversibly control DNA exposure/sequestration, cell 
polarity, tumor morphology, and ultimately, tumor behavior?  
 
 
Materials and Methods 
Cell lines and Cell culture 
MCF10A, a nonmalignant human breast epithelial cells was obtained from American 
Type Culture Collection (Rockville, MD); the spontaneously transformed and malignant 
human breast epithelial line, HMT-3522 T4-2, was isolated by (Briand et al., 1996) and 
was from the laboratory of  Mina J Bissell at Lawrence Berkley National Lab. MCF10A 
cells were maintained in DMEM/F12 (Biowhittaker, Inc. Walkersville, MD) containing 20 
ng/mL EGF (Calbiochem, Corp, San Diego, CA), 1.4 x 10-6 M hydrocortisone (BD 
Bioscience, San Jose, CA), 0.1 ng/mL Cholera toxin (Sigma, St Louis, MO), 10 X 10-6 
g/mL human Insulin (Calbiochem Corp.), 2 mM Glutamine L, 5% horse serum (Fisher, 
Ontario, Canada) and penicillin/streptomycin.  HMT-3522 T4-2 cells were routinely 
grown in H14 medium without 10 ng/ml EGF on Vitrogen-coated plates  (Biowhittaker, 
Inc. Walkersville, MD) as described (Weaver et al., 2002). 
 
3-D Cultures 
Three-dimensional cultures were prepared based on previously described protocols 
(Debnath et al., 2003; Weaver et al., 1997) with some modifications: Cover slips  (18 x 
18 mm) were coated with 120 µl of Reduced growth factor Matrigel (BD Bioscience, San 
Jose, CA). Single cell suspensions (0.5 - 1.0 X 105 cells per slip) were seeded on top of 
polymerized Matrigel, incubated for 30 min and over-laid with 2.5 ml of culture medium 
containing no EGF or serum. Cells were overlaid with medium containing 2% Matrigel. 
Cultures were grown for days indicated in figure legends, adding new medium every 
third day. 
 
 
 
DNA Digestion Assay 
  
Cell smear assays were performed as described previously (Maniotis et al., 2005). 
Briefly, monolayer cultures grown on 10 cm dishes (70-90 % confluent) were 
mechanically dislodged or trypsinized off the plate, collected by centrifugation, re-
suspended in serum-free DMEM. A drop (20 µl) of the suspension was placed on a glass 
slide and dried for 1 hour. DNA digestion was initiated by adding 50 µl of serum free 
DMEM containing 0.5 µl of 10 U/µl AluI (Promega, San Luis Obispo CA) restriction 
enzyme (5 U per smear) for 30-90 min, and terminated by adding 1 µg/ml Ethidium 
bromide (Fisher Scientific) to stain DNA. Nuclei were observed and photographed using 
a Leica inverted fluorescent microscopy (Leica, Bannockburn, IL). 
 
DNA digestion was performed on cells in 3-D cultures grown for 14 days.  In preliminary 
experiments, we first determined both the time and concentration of AluI required for 
DNA digestion taking into account that large aggregates of T4-2 contains more DNA 
than smaller MCF10A acini. Eight hours digestion using 60 Units of AluI was sufficient 
for complete digestion of MCF10A organized acini. The T4-2 aggregates still exhibited 
partial resistance to digestion after 36 hours of digestion using a total of 600 Units AluI 
(added 200 Units every 12 hour) suggesting that the difference in DNA digestion is not 
due to differences in the amount of DNA contained in the 3-D cultures  
   
Both Triton X-100 (0.1%) and NP-40 (0.1%) were tested as detergents to permeabilize 
cells in 3-D cultures to explore if the detergent per se affected DNA digestion. No 
difference in sensitivity to DNA digestion was observed using either one of these 
detergents, however NP-40 restored the normal morphology (round shape) of nuclei 
better than Triton X100 making it easier to evaluate the results. Cells in 3-D cultures 
grown 14 days were first permeabilized for 15 min with 0.1% NP-40, rinsed gently 3 
times in PBS and incubated with serum-free DMEM containing AluI restriction enzyme 
(Promega, San Luis Obispo CA) for 24h in an incubator at 37˚C. Three-dimensional 
cultures of MCF10A acini, HMT-3522 T4-2 aggregates and HMT-3522 T4-2 revertants 
were digested with 20 µl AluI (100 U/ml of media) added twice (total 400U/reaction) 
within a 24-hour incubation period. Ethidium bromide (0.5 µg/ml) was added to label 
DNA at the termination of the reaction. Nuclear fluorescence was photographed with a 
Leica inverted fluorescent microscope. Parallel cultures in each experiment were stained 
with Trypan blue (MP Biomedicals, Ohio) to confirm complete permeabilization.  
  
Flow Cytometry 
Cells from monolayer cultures of MCF10A and T4-2 were harvested either by scraping 
or trypsinization, diluted in PBS, and collected by centrifugation. The pellet was re-
suspended in 0.1% NP-40 and incubated for 1 min at room temperature to permeabilize 
the cells, followed by a second spin to wash away detergent. Pellets were re-suspended 
in 0.5 ml of regular DMEM with 65 U of AluI and incubated for 1h under rotation at 37˚C. 
Propidium iodide (1 µg/ml, Invitrogen/Molecular Probes, Carlsbad, CA) was added 
directly to each reaction at its conclusion, and the cell suspension was filtered through 
flow tubes with a filtered cartridge before flow cytometric analysis.  
 
After treating T4-2 non-reverted and reverted cells from 3-D cultures with Dispase (BD 
Bioscience, San Jose) for 30 min at 37˚C to degrade Matrigel proteins, cells were 
harvested into 15 ml Falcon tubes and re-suspended. To disperse the structures into 
single cell suspension, Trypsin (0.25%) was added (200 ul) and incubated for 5 min at 
37°C. Single cells were collected by centrifugation and re-suspended in PBS containing 
1µg/ml propidium iodide (Invitrogen/Molecular Probes, Carlsbad, CA). Cell suspensions 
were filtered through Flow tubes with a filtered cartridge and taken to flow cytometric 
analysis. All analyses were performed on a FACS Calibur (BD Bioscience, San Jose) 
equipped with a 488 laser for forward and side scatter, and 520, 575 and 675 nm 
detectors. Each run ended at 10,000 counts and was analyzed using FACS dot-plots 
and histograms. Propidium iodide signal represents labeled DNA, and signal intensity of 
undigested DNA (roughly corresponding to fluorescent intensity 102-104) was gated as 
M2. Lower signal intensity representing digested DNA (shorter DNA fragments) was 
gated as M1.  
 
Phenotypic Tumor Reversion with PI3K inhibitor and or dibutyryl-cAMP 
Cells were seeded on Matrigel as described above, overlaid with 2.5 ml of growth 
medium containing 8 µM PI3K inhibitor LY294002 (Calbiochem/EMD Biosciences, Inc.) 
San Diego, CA), or a combination of 6 µM LY294002 and 1 mM N6-dibutyryl-cAMP 
(Sigma-Aldrich St Louis, MO)). Cultures were maintained for 14 days with addition of 
new drugs every third day. No toxicity was observed in either normal or tumorigenic 3-D 
cultures of mammary epithelial cells at these drug concentrations. Dibutyryl-cAMP 
analog, in addition to elevating cAMP within the cell, metabolizes to butyrate, which 
alone is known to have distinct biological effects. However sodium butyrate, in 
concentrations ranging from 1-2mM, did not induce tumor reversion when added to the 
T4-2 cell cultures, thus eliminating a possible butyrate effect involved in tumor reversion. 
In experiments testing cAMP analog specificity and tumor reversion, cells were seeded 
as above and overlaid with medium containing either 0.5 mM 8-CPT-2´-O-Me-cAMP 
(BioLog Life Science, Bremen, Germany) or 0.5 mM N6-Monobutyryl-cAMP (BioLog Life 
Science).  
 
Phenotypic Tumor Reversion with Antibodies to Extracellular Matrix Proteins 
Cells were seeded on Matrigel as described above, and overlaid with 2.5 ml medium 
containing one of the following antibodies:rabbit anti-human fibronectin (A0245, Dako, 
Carpineria, CA, 1:100 dilution), mouse anti-human laminin (Lam-89, Sigma-Aldrich, St 
Louis, MO, 1:100 dilution), mouse anti-human Collagen IV (CIV22, Dako, Carpineria, 
CA, 1:100 dilution), rabbit anti-human Collagen I (CL50111AP, Cedarlane, Hornby, 
Ontario, 1: 100 dilution) and mouse anti-human gamma-tubulin (Sigma-Aldrich St Louis, 
MO). The cultures were fed every third day by overlay with 1 ml of medium containing 
fresh antibody. 
 
Immunofluorescence Microscopy 
Cells were cultured on top of a Matrigel-covered cover slip for 14 days as described 
above. Cover slips were washed 3 times with cytoskeleton extraction buffer (50 mM 
HEPES, 300 mM sucrose, 100 mM KCl, 5 mM MgCl2, 5 mM EDTA, 0.5 % Triton X-100, 
containing 1 mM sodium orthovanadate, 20 mM sodium fluoride and 20 µl/ml protease 
inhibitor cocktail from Sigma-Aldrich for 3 sec, rinsed with 1 X PBS and fixed in 100% 
ice-cold methanol (5 min in –20˚C) followed by 5 min incubation in ice-cold 100% 
acetone. Cells were rinsed 3 times in 1 x PBS and incubated over night at 4˚C with 
mouse anti-human β4 intergrin (clone E31) at a 1:200 dilution (Chemicon, Temecula, 
CA) or mouse anti-β-catenin (clone 14) at 5 µg/ml dilution  (BD Transduction Labs, San 
Jose, CA). Slides were washed 3 times for 2 - 5 min, incubated with a 1:200 dilution of 
goat anti-mouse secondary antibody conjugated to Alexa Fluor 546 (Molecular Probes) 
for 30 min at, washed 3 x (as above) and mounted on glass slides in Vectashield 
mounting medium (Vector Laboratories, Burlington, CA). Control cultures for all 
experiments were treated with the same concentration of non-specific rabbit IgG  (Cat. 
No. ab27478; Abcam, Cambridge, MA). The cultures were fed every third day by overlay 
of 1ml medium containing fresh antibody. 
 
Laser Scanning Confocal Microscopy 
Confocal images were taken on a Zeiss LSM510 laser scanning microscope (Carl Zeiss 
Micro Imaging Inc., Thornwood, New York, USA) using Incident Light Fluorescence and 
Differential Interference Contrast (DIC) with 25X and 63X water immersion objectives. 
Argon laser was applied for red fluorescence (AlexaFluor 546 and EtBr2 at 543 nm 
wavelength) and UV laser for blue fluorescence (DAPI at 405 nm wavelength). Images 
were captured using LSM Software Reliase 2.5 on a standard high-end Pentium PC. 
 
Results 
Phenotypic reversion of tumorigenic T4-2 cells   
The behavior of T4-2 tumorigenic cells in 3-D culture conditions was compared with 
normal MCF10A breast epithelial cells. After 10 to 14 days, MCF10A cells formed 
polarized acini (Figure 1 A) with the nuclei arranged circumferentially around the hollow 
interior. β4-integrin was distributed in a circular ring, facing the extracellular matrix 
environment (Figure 1B) and β-catenin was identified internally on cell surfaces between 
different cells comprising the multi-cellular acini (Figure 1C). By contrast, within 10 to 14 
days, T4-2 cells developed into disorganized aggregates (Figure 1D) that were 
considerably larger than polarized structures formed by MCF10A cells (note differences 
in scale bar sizes) (Figure 1). In the disorganized T4-2 aggregates, β4-integrin 
distribution was observed on cell surfaces facing all directions, both between cells and 
on surfaces facing the extracellular environment (Figure 1E). Also, in the disorganized 
T4-2 aggregates, β-catenin was distributed in and between most of the cells (Figure 1F). 
Compared to the architecture of MCF10A acini, the disorganized T4-2 aggregates 
appeared to exhibit complete loss of polarization. 
 
Tumorigenic T4-2 cells can be induced to develop into architecturally-normal acinus-like 
structures in vitro when cultured in the presence of a PI3K inhibitor, and these acinus-
like structures exhibit non-tumorigenic behavior in nude mice (Wang et al., 2002; 
Weaver et al., 2002; Weaver et al., 1997). We confirmed the in vitro reversion of 
tumorigenic T4-2 cells by culturing on Matrigel in the presence of 8 µM PI3K inhibitor 
LY294002 (not shown) consistent with the findings of (Liu et al., 2004; Wang et al., 2002; 
Weaver et al., 2002; Weaver et al., 1997). We also obtained phenotypic reversion using 
dibutyryl-cAMP at a concentration of 1mM (not shown), consistent with previous 
observations of phenotypic tumor reversion of monolayer cultures (Krystosek et al., 
1990).  
  
A combination of 6 µM LY294002 PI3K inhibitor and 1mM dibutyryl-cAMP induced the 
formation of reverted structures most similar to the acini formed by MCF10A cells in 
terms of size, polarization, and lumen formation (Figure1). In the acini formed by the 
reverted T4-2 cells, a dense ring of β4-integrin surrounded each spheroid (Figure 1H), 
similar to the ring of integrin formed around normal MCF10A structures (Figure 1B). In 
addition, β-catenin was redistributed from a disorganized haphazard pattern in the non-
drug-treated T4-2 aggregates, to a lace-like or stellar pattern of the drug treated 
structures (compare Figure 1F and I) that closely resembled β-catenin distribution in 
MCF10A cells in 3D culture conditions (compare Figure 1C and I). Moreover, acinus-like 
structures formed by T4-2 cells exposed to the combination of LY294002 PI3K inhibitor 
and dibutyryl-cAMP, were hollow, similar to the MCF10A acini (see Figure 1B and H). 
Therefore, because of the degree of fidelity we observed in the architecture of the 
revertants compared to normal MCF10A structures when using the combination of 6 µM 
LY294002 PI3K inhibitor and 1mM dibutyryl-cAMP, this treatment was employed as our 
standard protocol to consistently induce revertants exhibiting acinus-like structures with 
size and phenotype most similar to MCF10A acini. 
 
Differential DNA digestion in normal versus tumorigenic mammary epithelial cells 
grown in 2-D cell cultures 
Consistent with our reported observations (Maniotis et al., 2005), a MCF10A cell-smear 
assay showed that the DNA in these cells was extensively digested after a 1.5 hour 
exposure to AluI restriction enzyme (Figures 2A, B). By contrast, DNA in the nuclei of 
malignant T4-2 cells appeared to be mostly undigested after 1.5 hours exposure to AluI 
(Figures 2C, D). To confirm these qualitative observations, DNA digestion was quantified 
by flow cytometry (see Materials and Methods). Under these conditions, a shift in the 
DNA profile of MCF10A cells was observed within 60 min of AluI digestion (Figure 2 E 
and F), while less of a change was observed for tumorigenic T4-2 cells treated in the 
same manner (Figure 2G and H). The DNA profile for non-treated and AluI-treated 
MCF10A and T4-2 cells was collected from 5 separate DNA digestion experiments and 
averaged (Figure 2I).  Figures 2J and 2K demonstrate the degree of AluI digestion in 
MCF10A and T4-2 cells that were subjected to flow cytometry analysis.  
 
Differential DNA digestion in normal versus tumorigenic mammary epithelial cells 
grown in 3-D cell cultures 
To explore the sensitivity of DNA to AluI restriction enzyme of cells exhibiting 3-D 
architectural structure we developed an assay for the digestion of cells in 3-D culture 
conditions by AluI (see Materials and Methods). MCF10A epithelial cells and T4-2 
tumorigenic breast carcinoma cells were cultured for 14 days on Matrigel and allowed to 
form small acinus-like structures or large disorganized aggregates, respectively (see 
Figure 1). Following permeabilization with 0.1% NP-40 for 10 minutes, nuclei and 
morphology remained intact (Figure 2L, M, N, O, P and Q) in the 3-D cultures of 
MCF10A and transformed T4-2 respectively. Furthermore, these conditions allowed 
sufficient permeabilization for complete uptake of Trypan blue in small acini or acinus-
like structures of MCF10A, reverted T4-2 (Figure 2R and S) and large transformed T4-2 
aggregates (Figure 2T), indicating that the 3-D structures were completely 
permeabilized. 
 
After incubation with AluI for 24h, the chromatin in MCF10A acini was completely 
digested (Figure 2U and Y). By contrast, chromatin in T4-2 cells forming disorganized 
aggregates resisted digestion in the same time period under identical conditions (Figure 
2V and Z). Thus, the chromatin of MCF10A cells assembled into acini was far more 
sensitive to AluI digestion than the chromatin of T4-2 cells assembled into disorganized 
multicellular aggregates (compare high magnification images Figures 2Y and Z).  
 
Reversible manipulation of phenotype and DNA sequestration  
We applied the reversible T4-2 system to test if there is a differential sensitivity to Alu I in 
DNA of reverted T4-2 cells forming acinis-like structures, compared to DNA in 
transformed T4-2 cells forming disorganized aggregates. Strikingly, under identical AluI 
digestion conditions, we observed that DNA in T4-2 disorganized aggregates (Figure 3A) 
was far more resistant to digestion than the DNA in T4-2 cells induced to form acinus-
like structures (revertants), by either PI3K inhibitor (not shown) or the PI3K inhibitor plus 
dibutyryl-cAMP (Figure 3B). The extent of differential digestion is clearly illustrated by 
images collected at a higher magnification (Figures 3E and F). Both T4-2 revertants and 
aggregate structures displayed an intact morphology as revealed by corresponding DIC 
images (Figure 3G and H). These results demonstrate for the first time that phenotypic 
tumor reversion is accompanied by a significant shift in chromatin sequestration.  
 
Exposure of T4-2 cells to PI3K inhibitor plus dibutyryl-cAMP (Figure 4B) resulted in the 
formation of organized acinus-like structures (Figures 3 C and D) that harbored DNA, 
which completely digested with AluI restriction enzyme. In contrast, the chromatin from 
non-reverted, disorganized T4-2 cell aggregates was more resistant to digestion.   The 
removal of PI3K inhibitor and dibutyryl-cAMP over a 14 day period caused the reverted 
T4-2 acinus-like structures to gradually grow larger, and become disorganized to a point 
where they were phenotypically identical to control, non-reverted T4-2 cells aggregates 
(Figure 3I, J, K and Figure 1 and 2).  As the reverted T4-2 cells changed morphologically 
from organized spheroids (day 0) to disorganized spheroids (day 7) and to disorganized 
aggregates without any evidence of polarity (day 15), DNA became more resistant to 
digestion with AluI restriction enzyme (Figure 3L, M, N, O, P, Q). Quantification using 
flow cytometry confirmed the visual comparisons of DNA digestion experiments (Figure 
3R). Taken together, reversible manipulation of 3-D cultures from a tumor-like 
architecture to a normal architecture, and back again, was consistently accompanied by 
reversible changes in DNA sequestration. 
 
Manipulation of morphology, polarization, and chromatin sensitivity to DNA 
digestion specifically involves a Protein Kinase  A (PKA) coupled signal 
Dibutyryl-cAMP has been reported to induce reverse transformation of a number of 
transformed cell lines grown in monolayer (Krystosek et al., 1990; Puck et al., 2002). 
Treatment with 1mM dibutyryl-cAMP was reported in 12 different tumorigenic cell lines to 
restore normal morphology and sensitivity to nuclear chromatin digestion by DNase I. 
Cyclic AMP has traditionally been thought to act exclusively through the cAMP-
dependent protein kinase A (Ashall et al., 1988; Walsh et al., 1968), and effects of cAMP 
on tumor reversion have been attributable to activation of PKA (Kim et al., 2000; 
Schonberg et al., 1983). However, the action of intracellular cAMP is not only mediated 
by PKA, but also by a newly recognized family of cAMP-binding proteins designated as 
cAMP-regulated guanine nucleotide exchange factors (also known as Epac) (de Rooij et 
al., 1998; Kawasaki et al., 1998). 
 
To discriminate between Epac and PKA coupled signals, we tested specific cAMP 
analogs for their ability to revert T4-2 cells in 3-D cultures. Monobutyryl-cAMP which is a 
poor agonist for Epac but a potent PKA activator (Christensen et al., 2003; Kopperud et 
al., 2003), phenotypically reverted the T4-2 cells into organized acinus-like structures 
(Figure 4A) as was seen for T4-2 cells treated with PI3K inhibitor plus dibutyryl-cAMP 
(Figure 2B). Beta  4-integrin distribution within the monobutyryl-cAMP-reverted acinus-
like structures appeared on the cell surfaces facing the microenvironment and these 
reverted structures appeared to be hollow in the center, confirming polarized 
organization (Figure 4C and D). Furthermore, the nuclei of these reverted T4-2 
spheroids were also sensitive to DNA digestion by AluI (Figure 4E and F). 
Parenthetically, the 8-CPT-2P-O-Me-cAMP analog (a selective and strong agonist for 
Epac (de Rooij et al., 1998)) did not revert tumorigenic T4-2 cells into polarized acinus-
like structures (Figures 4G-H): β4-integrin was randomly distributed on cell surfaces 
throughout the disorganized cell aggregates (Figure 4 I and J), and the nuclei were 
resistant to DNA digestion by AluI (Figure 4K and L).  
 
Antibody interference of extracellular matrix components drives phenotypic tumor 
reversion, induces polarization, and exposes sequestered DNA 
We next aimed to determine if changes in the interaction between T4-2 cells (forming 
either aggregates or reverted acinus-like structures) and the ECM influenced the 
phenotype, structural polarity, and DNA organization. T4-2 cells were cultured in Matrigel 
with antibodies targeting individual ECM components including: fibronectin (FN), 
collagen I (Col I), collagen IV (Col IV), and laminin (LM) (Table 1 and Figures 5A-D).   
The treatment of T4-2 cells with each of these antibodies induced changes in phenotypic 
behavior that were evident as early as 6-7 days (data not shown) and more pronounced 
by day 14 when compared to cultures treated with IgG as a control. (Figure 5E). Anti-FN 
antibody treatment completely reverted the T4-2 cells to acinus-like morphology (Figure 
5A), indistinguishable from revertants produced via the combination of PI3K inhibitor and 
dibutyryl-cAMP or with monobutyryl-cAMP analog alone (compare with Figure 5A with 
Figure 4A and B). Cells grown in the presences of anti-Col I antibody and anti–Col IV 
antibody obtained a spherical morphology (Figure 5B and C). Anti-LM treated cultures 
tended to exhibit horizontal plaque-like structures (Figure 5D). We specifically tested in a 
separate series of experiments if sodium azide may have a synergistic affect on tumor 
reversion since the antibody solvent contains low concentrations of sodium azide. The 
results of these experiments demonstrated that sodium azide had no effect by itself or in 
combination with control antibodies used in these experiments (data not shown). 
 
We next explored if these antibody-induced morphological changes were accompanied 
by changes in polarization.  To test this, T4-2 cells grown on Matrigel for 14 days in the 
presence of various antibodies were immunostained with anti- β4-integrin antibody. In 
this experiment, T4-2 revertants were produced via exposure to PI3K inhibitor and 
dibutyryl-cAMP to serve as controls for normal acinus-like morphogenesis. (Figure 5F 
and F'). Remarkably, T4-2 cultures exposed to anti-FN antibody exhibited polarized 
hollow lumen, and β4-integrin was distributed on the acinus-like surfaces facing the ECM 
(Figure 5 G and G'), identical to the standard controls (Figure 5F), Anti-Col I antibody 
induced spherical structures, however, they did not appear hollow nor were they 
polarized as suggested by the random distribution of β4-integrin (Figure 5H and H'). Anti-
LM antibody-treated cultures also did not appear to be polarized and exhibited long 
strings of β4-integrin staining between the horizontal cell plaques (Figure 5I). Cells 
grown in the presence of non-specific IgG served as a negative control with respect to 
polarization and behaved similar to untreated cultures  (Figure 5J and K). 
We next wanted to determine the nuclease sensitivity of DNA from cells that assumed 
polarized structures after treatment with an anti-FN antibody and to compare this 
sensitivity with that of cells treated with an anti-laminin antibody that induced the 
smallest degree of morphological reversion. In this experiment, we included untreated, 
transformed T4-2 aggregates and PI3K inhibitor/dibutyryl-cAMP- reverted T4-2  acinus-
like structures as controls for sequestered and exposed chromatin, respectively (Figure 
5L-O).The nuclei of anti-fibronectin-revertants harbored completely digested DNA after 
24h of digestion with AluI (Figure 5P-S), similar to T4-2 revertants (Figure 5 N and O) 
obtained by the standard protocol. The cells in the plaque-like anti-LM treated cultures, 
by contrast, harbored chromatin that was resistant to 24 hours of AluI digestion (Figure 
T-W), similar to chromatin in the transformed T4-2 aggregates (Figure 5L). 
 
 
Discussion 
We have shown that the DNA of non-malignant breast epithelial cells that form polarized 
acini, are exposed to AluI digestion, while, tumorigenic cells that form disorganized, non-
polarized aggregates, exhibit profound sequestration of their DNA under identical 
enzymatic digestion conditions. Tumorigenic T4-2 cells induced to form polarized acinus-
like structures displayed a level of sensitivity to AluI that was comparable to that 
observed in normal MCF10A cells when assembled into acini. Thus, the act of T4-2 cell 
polarization and assembly into an acinus-like structure shifted the chromatin 
organization of these cells, causing previously sequestered DNA to assume a more 
open conformation with increased accessibility to AluI.   
 Also, when established reverted T4-2 acinus-like structures are released from agents 
that induce polarity, they grow into disorganized, unpolarized, aggregates. This shift from 
a reverted to a tumorigenic morphology is accompanied by a shift in chromatin 
organization from an exposed to a sequestered state. From these results, we conclude 
that chromatin organization is coupled to tissue architecture, and can be reversibly 
manipulated. More specifically, chromatin organization is linked to cell polarity, and the 
3-D organization of cells in an extracellular environment. 
 
Many different in vitro and in vivo observations support the fact that transformations in 
phenotype and DNA sequestration are not enzymatic artifacts (Maniotis et al., 2005). 
For instance, we previously showed that the DNA in human cancer cells is tightly 
packaged in vitro, making it less susceptible to digestion by restriction enzymes 
(Maniotis et al., 2005). Most importantly, touch preparations made from comparing 
human lesions with their margins in the normal tissue, all demonstrate that the more 
invasive the cancer, the better its DNA is protected from restriction enzyme cleavage 
(Maniotis et al., 2005). Therefore, enhanced DNA protection has now been observed in 
many different types of cancer, and is reversible, suggesting that DNA re-arrangements 
as described here may be a universal feature of malignant cells. The fact that 
sequestration of DNA, and the molecular consequences of such, serve as a physical 
marker for malignancy, may be applicable in other types of cancer detection as well. 
Therefore chromatin organization analysis may be a supplement for current methods of 
cancer diagnostics which detect chemical markers that are highly variable from tumor to 
tumor and from patient to patient, or which are highly specific for certain types of tumors.  
 
In devising the most optimal conditions for generating polarized acinus-like structures 
from T4-2 cells, we discovered that a cocktail of two reagents that can each alone revert 
T4-2 cells produced the most consistent development of acinus-like, polarized 
structures. These reverted structures resembled the polarized acini generated by non-
malignant MCF10A cells. This finding supports previous studies using PI3K inhibitor 
(Wang et al., 2002) or an analog of dibutyryl-cAMP for tumor reversion (Krystosek et al., 
1990; Puck et al., 2002). In addition, we show for the first time that these reagents are 
able to revert cancer cells in a 3-D context. Biochemically, the action of intracellular 
cAMP can be attributed to activation of at least two intracellular substrates, PKA and 
EPAC (de Rooij et al., 1998; Kawasaki et al., 1998).  Using specific cAMP-analogs that 
discriminate between the activation of these substrates (Christensen et al., 2003; 
Kopperud et al., 2003), we found that the reversion of T4-2 morphology, polarity, and 
AluI sensitivity exclusively involves a PKA-coupled signal.  
 
Unraveling the complexity of DNA packaging or sequestration in its native state within 
the intact cell nucleus may suggest a new possible mechanistic explanation of how 
eukaryotic genes are turned on or off, and how they are reversibly expressed or 
suppressed. From a mechanistic point of view, these experiments employing in situ DNA 
digestion with AluI indicate that higher order structure of native chromatin is organized 
such that the sequestration and exposure of DNA is linked to cytoarchitecture (cell 
polarity, cell shape, organoid 3-D architecture). Because DNA, the substrate, must be 
exposed to AluI, the enzyme, in order to be digested, the AluI insensitive revertants 
(DNA sequestered), or the AluI sensitive tumorigenic (DNA exposed) phenotypes 
suggests that proteins organizing higher order chromatin structure are capable of 
reversibly enveloping the DNA as a tightly-wrapped spring (resembling a sleeve), in 
which the DNA can be reversibly exposed or sequestered (Maniotis et al., 2005). Such 
an hypothesis provides a mechanistic picture of how higher order chromatin in the living 
state may grouped together, to expose or sequester DNA in regular patterns. This may 
in turn account for specific malignant cancer, non-malignant cancer, or normal gene 
expression and phenotypic expression types.  
 
When tumorigenic viruses, or when highly invasive tumor cells are placed into embryos, 
tumors do not form, which suggests that the behavior of cancer is contextual (Dolberg 
and Bissell, 1984; Kulesa et al., 2006; Mintz and Illmensee, 1975). These studies 
demonstrate that when highly invasive tumor cells are placed into the complex milieu of 
soluble and insoluble factors within the embryo, they become “regulated,” to behave as 
normal cells, without causing cancer in the mosaic organism that develops. If tumor cells 
are implanted early enough during embryogenesis, some of the tumor cells are passed 
down through the germ line, and to the mosaic organism’s descendents without causing 
cancer in these mosaic organisms (Mintz and Illmensee, 1975). Importantly, context-
regulation of cancer cells in the embryonic environment occurs even when the cancer 
cells have already metastasized from their primary tumor site (Kulesa et al., 2006). This 
suggests that context-regulation of cancer cells is possible despite deregulation of 
proteins, of cell structure, of cell cycle, of telomerase activity, and occurs independent of 
mutations, aberrations of oncogenes, and aneuploidy. 
 
It is known that the ECM by itself can provide signals that are relayed from integrin 
receptors on the cell surface to the nucleus by (Ingber et al., 2003; Maniotis et al., 1997; 
Roskelley and Bissell, 2002). Therefore, we explored if tumor reversion, and the 
accompanying chromatin reorganization, could be obtained by interfering only with 
specific cues from the ECM using antibodies to proteins found in our malignant tumor 
samples. In particular, we specifically targeted those ECM components that have been 
reported to be highly expressed by various tumors (Ioachim et al., 2002; Ioachim et al., 
2005; Lin et al., 2005).  The different antibodies used, all induced profound changes in 
the development and the resulting morphology of T4-2 structures (see Table 1 and 
Figure 5). Of key importance, the structures induced by anti fibronectin exhibited 
chromatin that was exposed in an identical fashion to chromatin of normal acini and 
chromatin in acinus-like structures produced by cAMP and PI3K inhibitor. By contrast, 
and at the other extreme, the anti laminin induced structures (large horizontal plaque-like 
structures) exhibited chromatin that was sequestered. 
 
Here we have shown that placing T4-2 cells in the context of a laminin-rich matrix in the 
presence of a single component such as anti-fibronectin induces complete phenotypic 
reversion from normal to tumorigenic phenotype, and from DNA being in a sequestered 
state or an exposed state, and that these states are reversible. These observations 
suggest that the components of the tumor microenvironment can be identified, isolated, 
and perhaps therapeutically exploited, as indicated in the reversion obtained with a 
single molecular species such as anti-fibronectin. 
 
Specific isoforms of fibronectin that are normally expressed in fetal tissue (George et al., 
1997; George et al., 1993), and rarely expressed in adult tissue, have been detected in 
different cases of human cancer (Schor et al., 1988). In addition, the B-isoform of 
fibronectin (EDB-fibronectin) plays a role in cellular transformation and tumor 
pathogenesis (Castellani et al., 1994; Kaczmarek et al., 1994; Labat-Robert, 2004; 
Midulla et al., 2000; Schor et al., 1986; Zardi et al., 1987), and a truncated isoform of 
fibronectin referred to as fetal migration stimulatory factor has been detected in the 
serum of 90% of breast cancer cases (Picardo et al., 1991), as well as in other human 
cancers (Durning et al., 1984; Schor et al., 2003; Schor et al., 1986). Elucidating the 
mechanisms through which ECM components influence tumor cell and DNA 
organization may lead to the identification of new potential targets for cancer therapy. 
 
In summary; 1) information conveyed from the extracellular matrix environment controls 
tissue phenotype, cellular and organoid, polarity, and DNA sequestration or exposure 2) 
shifts in cellular polarity and chromatin organization are concomitant events, and 3) 
agents targeting multiple signaling pathways (eg. PI3K, PKA, and fibronectin) evoke 
identical phenotypes (and chromatin exposure). The causal determinants of indolent or 
malignant cancer cell behavior and chromatin organization appear to be epigenetic 
rather than genetic in nature, and these signaling pathways can be manipulated from 
outside of tumor cells by selecting specific molecular targets within the extracellular 
matrix.  
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Figure legends 
Figure 1.  Restoration of mammary cell polarization and morphogenesis from 
tumorigenic to normal by experimentally manipulation in the context of ECM. 
Zeiss LSM 510 laser Scanning confocal images revealing the morphology and 
polarization of  MCF10A acini (A-C), transformed tumorigenic T4-2 aggregates (D-F) 
and reverted T4-2 acinus like structures (G-I) in 3D culture. A, D, G represent Differential 
Interference Contrast (DIC) micrograph of two-week old cultures on Matrigel fixed and 
immune stained as described in materials and methods. B, E and H show localization of 
β4-integrin revealed by immune-staining and fluorescent laser Scanning confocal. C, F 
and I represent the distribution of beta catenin revealed by immune staining. Alexa 546-
immune-labeled proteins (β4-integrin or β-catenin) are seen as red fluoresecent and blue 
fluorescent represent nuclei stained with DAPI. Reversion of T4-2 was obtained with a 
combination of PI3K-inhibitor LY290042 and dibutyryl-cAMP as described in materials 
and methods. 
 
Figure 2. Differential DNA digestion of chromatin harbored in normal versus 
tumorigenic mammary epithelial cells grown in 2- and 3- D cell cultures. 
Fluorescent micrograph of nonmalignant (MCF10A) and tumorigenic (T4-2) mammary 
epithelial lines. The dry monolayer smears of each culture was incubated without  (A and 
C) or with Alu I (B and D) for 1.5 h at 37˚C and stained with EtBr, to analyze the digested 
DNA by fluorescent microscopy. E-H represents flow cytometry comparing the DNA 
profile of nonmalignant MCF10A and tumorigenic T4-2 cells before (E and G) and after 
(F and H) 60 min of Alu I digestion respectively. DNA profile was determined by 
fluorescent intensity of propidium iodide and was used as a measure of DNA digestion. 
The gating for M1 and M2 indicates nucleus off cell cycle (digested) and in cell cycle 
(undigested). J and K represent fluorescent high magnification micrographs visualizing 
the amount DNA digestion in nonmalignant MCF10A and tumorigenic T4-2 nuclei treated 
similar to samples applied in flow cytometry. A Graphical illustration of flow cytometry 
analysis measurements of nonmalignant (MCF10A) and tumorigenic (T4-2) chromatin 
digestion is shown in panel I. Percent DNA digestion is determined by relative increase 
of fluorescent intensity gated in M1 before and after digestion. Error bars indicate the 
standard error over mean from 5 separate identical experiments. Laser Scanning 
confocal images comparing chromatin of undigested DNA in nonmalignant MCF10A  
(L, P) and tumorigenic T4-2 (M, Q) cells cultured for two weeks on Matrigel, 
permeabilized and stained as described in Materials and Methods. Bright field images of 
3-D cultures treated as described above followed by Trypan blue staining, was included 
to illustrate complete permeabilization of MCF10A acini  (R), reverted T4-2 acinus-like 
structures (S) and transformed T4-2 aggregates (T). Laser Scanning confocal images 
comparing chromatin of Alu I digested DNA in nonmalignant MCF10A acini (U, Y) and 
transformed T4-2 aggregates (V, Z). Cultures were permeabilized as described above 
before Alu I treatment (W, X) and nuclei were stained with EtBr and DAPI and observed 
by fluorescence laser imaging. Note the complete digested nuclei revealed by higher 
magnification micrographs of normal spheroids in contrast to the almost undigested 
nuclei in tumorigenic aggregates.  
 
Figure 3. Reversible manipulation of phenotype and genome sequestration 
Laser Scanning confocal images comparing DNA digested chromatin in transformed T4-
2 aggregates (A,C,F,G) and reverted T4-2 acinus-like structures (B,D,E,H). Cells were 
grown for two weeks on Matrigel without (A,C,F,G) and with 6 µM LY294002 and 1mM 
dibutyryl-cAMP (B,D,E,H), followed by permeabilization and AluI digestion for 24h as 
described in materials and methods. Digested nuclei were stained with EtBr and 
observed by fluorescence laser imaging (B,D) and bright-field images were obtained by 
DIC (C,D,G,H). Note in the higher magnification images that only the nucleolus remains 
undigested in the nuclei of completely digested T4-2 revertants (E), in contrast to only 
partially digested chromatin in transformed T4-2 (F). These data are representative 
images of observations obtained from 5 separate identical experiments. I-K are phase 
contrast images of revertant T4-2 acinus-like structures treated for two weeks with 6 µM 
LY294002 and 1mM dibutyryl-cAMP and then released from drug at day 0 (I), day 7 (J) 
and day 15 (K) after drug release. L-Q are Laser scanning confocal images of T4-2 
cultures treated similar to I-K, followed by permeabilization and 24h AluI incubation. 
Fluorescent micrographs (based on EtBr stained DNA) reveal DNA digestion by Alu I at 
day 0 (L), day 7 (M) and day 15 (N) after drug release. Note the gradual shift from 
normal to tumorigenic morphology accompanied by a similar shift in AluI sensitivity. O, 
P, Q are bright-field image obtained by DIC corresponding to L, M, N. These data are 
representative for 3 separate identical experiments. The percentage of digested DNA 
before and after Alu I digestion on revertant T4-2 at day 0, day 7 and day15 after drug 
release (similar to above) is listed in panel R. Quantitation of digested DNA was 
performed by Flow cytometry analysis and measured as signal-intensity gated in M1 see 
Materials and Methods. Numbers represent the mean of 3 separate identical 
experiments. 
 
Figure 4. cAMP-induced  reversion of morphology, polarization and chromatin 
organization involves a PKA coupled signal 
A-D are phase contrast micrographs comparing the morphology of T4-2 cells grown for 
14 days on Matrigel in the presence (A,B,G) or absense (H) of different cAMP analogs; 
N6-monobutyryl-cAMP (A), dibutyryl-cAMP + LY294002 (B), 8-CPT-2-O´-Me-cAMP (G) 
or untreated (H). Laser scanning images revealing the β4-integrin localization in T4-2 
cultures treated for two weeks with either N6-monobutyryl-cAMP (D) or no drug (J) 
followed by immune staining as described in Materials and Methods. Red indicates β4-
integrin and blue show DAPI stained nuclei. Corresponding bright field images to D and 
J are shown by DIC in (C and I respectively). Laser scanning images revealing nuclei of 
T4-2 cultures treated for two weeks with either monobutyryl-cAMP (F) or no drug (L) 
followed by permeabilization, 24h AluI digestion and EtBr staining as previously 
described. Corresponding bright field images to F and L are show by DIC in (E and K 
respectively). These data are representative for three separate identical experiments. 
 
Figure 5. Reversion of morphology, polarization and chromatin organization by 
interfering with the communication of ECM components.  
Phase contrast micrographs comparing the morphology of T4-2 cells grown for 14 days 
on Matrigel in the presence of different antibodies; treatment with anti- fibronectin (anti-
FN, A), anti-collagen I (anti-COL I, B), anti-collagen IV (anti-COL IV, C), anti-laminin 
(anti-LAM, D), non specific IgG (IgG, E). All images (A-E) are at 200 X magnifications.  
Laser scanning confocal images of T4-2 cells grown and treated as described in A-E, 
followed by immune staining with anti- β4-integrin (shown in red) to reveal structural 
polarization in anti-fibronectin treated cultures (G), anti collagen I treated cultures (H), 
anti laminin trated cultures (panel I) and IgG treated cultures (J). T4-2 cells treated with 
combination of 6 µM LY294002 and 1mM dibutyryl-cAMP (cAMP cocktail, F) represents 
a polarized control and untreated cultures (Untreated, K) represent an unpolarized 
control. Blue represent DAPI stained nucleus (se Materials and Methods). 
Corresponding fields to fluorescent images in F-K are represented in bright field 
(obtained by DIC) in F´-K´ respectively. L-W are Laser scanning images of T4-2 cells 
grown and treated as above followed by permeabilization, 24h AluI digestion and EtBr 
staining (see Materials and Methods). Alu I digested T4-2 aggregates (untreated, L, M) 
and reverted T4-2 (cAMP-cocktail, panel N,O) represent controls for AluI resistant and 
sensitive chromatin respectively. Both low and high magnification images are shown of 
AluI digested T4-2 cultures treated with anti-fibronectin (anti-FN, P-S) and anti-laminin 
(anti-LAM, T-W). Corresponding DIC images are shown to the left of each fluorescent 
micrograph (M, O, Q, S, U, W).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1. 
T4-2 cultures1 Morphology Polarization2 DNA digestion3
Untreated  Disorganized 
aggregate 
- Resistant 
LY249002/dibutyryl-cAMP Acinus-like + Sensitive 
Anti fibronectin Acinus-like + Sensitive 
Anti collagen I Spheroid - ND 
Anti collagen IV Spheroid ND ND 
Anti laminin Horizontal plague - Resistant 
Anti IgG Disorganized 
aggregate 
- Resistant 
 
1 Cultures of T4-2 cells grown in 3-dimmension for 14 days in the presences of 
different agents (as indicated) before analyzed. 
2 Determined by β4-integrin distribution (revealed by immune staining) and hollow lumen (revealed by 
nucleus orientation). See Materials and Methods. 
3 The sensitivity of DNA was determined by 24h Alu-I digestion (Materials and Methods) 
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